Technology
Health
Biotechnology
Immutep
$1.969876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.06 (-2.97%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Immutep and other stocks, options, ETFs, and crypto commission-free!
About
Immutep Limited American Depositary Shares, also called Immutep, is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. Read More The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
CEO
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1987
Market Cap
65.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
135.66K
High Today
$2.05
Low Today
$1.92
Open Price
$2.03
Volume
18.99K
52 Week High
$4.21
52 Week Low
$1.77
Collections
Technology
Health
Biotechnology
Cancer Prevention
Research And Development
Medical
News
Yahoo FinanceMay 10
Immutep Announces Upcoming Industry Conference Participation
SYDNEY, Australia, May 10, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announces participation at upcoming industry conferences.
Price Paid on Robinhood
30% Lower
Right Now
52 Week Low
$1.77
Average Price Paid
$2.78
52 Week High
$4.21